nodes	percent_of_prediction	percent_of_DWPC	metapath
Anastrozole—CYP1A2—Fluorouracil—head and neck cancer	0.135	0.359	CbGbCtD
Anastrozole—CYP2C9—Fluorouracil—head and neck cancer	0.121	0.323	CbGbCtD
Anastrozole—CYP3A4—Vinblastine—head and neck cancer	0.0654	0.174	CbGbCtD
Anastrozole—CYP3A4—Docetaxel—head and neck cancer	0.0539	0.144	CbGbCtD
Anastrozole—Emotional distress—Hydroxyurea—head and neck cancer	0.0155	0.028	CcSEcCtD
Anastrozole—Lymphoedema—Docetaxel—head and neck cancer	0.0141	0.0254	CcSEcCtD
Anastrozole—Thromboembolic event—Docetaxel—head and neck cancer	0.0127	0.023	CcSEcCtD
Anastrozole—Emotional distress—Fluorouracil—head and neck cancer	0.0112	0.0202	CcSEcCtD
Anastrozole—Digestion impaired—Hydroxyurea—head and neck cancer	0.00988	0.0178	CcSEcCtD
Anastrozole—Blister—Hydroxyurea—head and neck cancer	0.00916	0.0165	CcSEcCtD
Anastrozole—Hepatotoxicity—Hydroxyurea—head and neck cancer	0.00855	0.0154	CcSEcCtD
Anastrozole—Bone pain—Vinblastine—head and neck cancer	0.00756	0.0136	CcSEcCtD
Anastrozole—Raised liver function tests—Docetaxel—head and neck cancer	0.00743	0.0134	CcSEcCtD
Anastrozole—Ulcer—Hydroxyurea—head and neck cancer	0.00698	0.0126	CcSEcCtD
Anastrozole—Blister—Fluorouracil—head and neck cancer	0.0066	0.0119	CcSEcCtD
Anastrozole—Neoplasm—Vinblastine—head and neck cancer	0.00655	0.0118	CcSEcCtD
Anastrozole—Neoplasm—Hydroxyurea—head and neck cancer	0.00597	0.0108	CcSEcCtD
Anastrozole—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.00591	0.0107	CcSEcCtD
Anastrozole—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00537	0.00969	CcSEcCtD
Anastrozole—Embolism—Docetaxel—head and neck cancer	0.00535	0.00965	CcSEcCtD
Anastrozole—Cyst—Docetaxel—head and neck cancer	0.00513	0.00927	CcSEcCtD
Anastrozole—Ulcer—Fluorouracil—head and neck cancer	0.00503	0.00907	CcSEcCtD
Anastrozole—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00502	0.00906	CcSEcCtD
Anastrozole—CYP1A2—Arylamine metabolism—NAT2—head and neck cancer	0.00501	0.0711	CbGpPWpGaD
Anastrozole—Inflammation—Fluorouracil—head and neck cancer	0.0049	0.00885	CcSEcCtD
Anastrozole—Hepatotoxicity—Docetaxel—head and neck cancer	0.00444	0.00802	CcSEcCtD
Anastrozole—Angina pectoris—Vinblastine—head and neck cancer	0.00443	0.00799	CcSEcCtD
Anastrozole—Myocardial ischaemia—Docetaxel—head and neck cancer	0.00427	0.00771	CcSEcCtD
Anastrozole—Ageusia—Docetaxel—head and neck cancer	0.00424	0.00765	CcSEcCtD
Anastrozole—CYP19A1—FSH signaling pathway—AREG—head and neck cancer	0.00417	0.0592	CbGpPWpGaD
Anastrozole—Depression—Vinblastine—head and neck cancer	0.00404	0.00729	CcSEcCtD
Anastrozole—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00399	0.00721	CcSEcCtD
Anastrozole—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00399	0.0072	CcSEcCtD
Anastrozole—Myocardial infarction—Vinblastine—head and neck cancer	0.00397	0.00717	CcSEcCtD
Anastrozole—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00397	0.00717	CcSEcCtD
Anastrozole—Swelling—Fluorouracil—head and neck cancer	0.00391	0.00706	CcSEcCtD
Anastrozole—Weight increased—Hydroxyurea—head and neck cancer	0.00377	0.00681	CcSEcCtD
Anastrozole—Haemoglobin—Vinblastine—head and neck cancer	0.00366	0.0066	CcSEcCtD
Anastrozole—Haemorrhage—Vinblastine—head and neck cancer	0.00364	0.00657	CcSEcCtD
Anastrozole—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00362	0.00654	CcSEcCtD
Anastrozole—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00361	0.00652	CcSEcCtD
Anastrozole—Pharyngitis—Vinblastine—head and neck cancer	0.00361	0.00652	CcSEcCtD
Anastrozole—Bone pain—Docetaxel—head and neck cancer	0.00358	0.00647	CcSEcCtD
Anastrozole—Inflammation—Docetaxel—head and neck cancer	0.00354	0.00639	CcSEcCtD
Anastrozole—Lethargy—Fluorouracil—head and neck cancer	0.00352	0.00636	CcSEcCtD
Anastrozole—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00349	0.00631	CcSEcCtD
Anastrozole—Osteoarthritis—Fluorouracil—head and neck cancer	0.00345	0.00623	CcSEcCtD
Anastrozole—Pulmonary embolism—Docetaxel—head and neck cancer	0.00343	0.0062	CcSEcCtD
Anastrozole—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00343	0.0062	CcSEcCtD
Anastrozole—Haemoglobin—Hydroxyurea—head and neck cancer	0.00333	0.00602	CcSEcCtD
Anastrozole—Influenza like illness—Docetaxel—head and neck cancer	0.00333	0.00602	CcSEcCtD
Anastrozole—Haemorrhage—Hydroxyurea—head and neck cancer	0.00332	0.00599	CcSEcCtD
Anastrozole—Neuropathy—Docetaxel—head and neck cancer	0.00322	0.00582	CcSEcCtD
Anastrozole—Alopecia—Vinblastine—head and neck cancer	0.00321	0.0058	CcSEcCtD
Anastrozole—Neoplasm—Docetaxel—head and neck cancer	0.0031	0.0056	CcSEcCtD
Anastrozole—Dysphagia—Fluorouracil—head and neck cancer	0.00298	0.00538	CcSEcCtD
Anastrozole—Ill-defined disorder—Vinblastine—head and neck cancer	0.00294	0.0053	CcSEcCtD
Anastrozole—Alopecia—Hydroxyurea—head and neck cancer	0.00293	0.00529	CcSEcCtD
Anastrozole—Anaemia—Vinblastine—head and neck cancer	0.00293	0.00528	CcSEcCtD
Anastrozole—Angina pectoris—Fluorouracil—head and neck cancer	0.00291	0.00525	CcSEcCtD
Anastrozole—Erythema—Hydroxyurea—head and neck cancer	0.00289	0.00521	CcSEcCtD
Anastrozole—Thrombophlebitis—Docetaxel—head and neck cancer	0.00288	0.00519	CcSEcCtD
Anastrozole—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00286	0.00517	CcSEcCtD
Anastrozole—Malaise—Vinblastine—head and neck cancer	0.00286	0.00515	CcSEcCtD
Anastrozole—Leukopenia—Vinblastine—head and neck cancer	0.00283	0.00512	CcSEcCtD
Anastrozole—Swelling—Docetaxel—head and neck cancer	0.00282	0.0051	CcSEcCtD
Anastrozole—Hypertension—Vinblastine—head and neck cancer	0.00273	0.00493	CcSEcCtD
Anastrozole—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00268	0.00484	CcSEcCtD
Anastrozole—Anaemia—Hydroxyurea—head and neck cancer	0.00267	0.00482	CcSEcCtD
Anastrozole—Discomfort—Vinblastine—head and neck cancer	0.00266	0.00481	CcSEcCtD
Anastrozole—Hot flush—Docetaxel—head and neck cancer	0.00266	0.00481	CcSEcCtD
Anastrozole—Menopausal symptoms—Docetaxel—head and neck cancer	0.00264	0.00477	CcSEcCtD
Anastrozole—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00262	0.00473	CcSEcCtD
Anastrozole—Myocardial infarction—Fluorouracil—head and neck cancer	0.00261	0.00471	CcSEcCtD
Anastrozole—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00261	0.00471	CcSEcCtD
Anastrozole—Dermatitis bullous—Docetaxel—head and neck cancer	0.00261	0.00471	CcSEcCtD
Anastrozole—Malaise—Hydroxyurea—head and neck cancer	0.0026	0.0047	CcSEcCtD
Anastrozole—Urinary tract infection—Fluorouracil—head and neck cancer	0.00259	0.00467	CcSEcCtD
Anastrozole—Leukopenia—Hydroxyurea—head and neck cancer	0.00258	0.00467	CcSEcCtD
Anastrozole—Lethargy—Docetaxel—head and neck cancer	0.00254	0.00459	CcSEcCtD
Anastrozole—Sinusitis—Fluorouracil—head and neck cancer	0.0025	0.0045	CcSEcCtD
Anastrozole—Anorexia—Vinblastine—head and neck cancer	0.00246	0.00445	CcSEcCtD
Anastrozole—Discomfort—Hydroxyurea—head and neck cancer	0.00243	0.00438	CcSEcCtD
Anastrozole—Haemoglobin—Fluorouracil—head and neck cancer	0.0024	0.00433	CcSEcCtD
Anastrozole—Rhinitis—Fluorouracil—head and neck cancer	0.00239	0.00432	CcSEcCtD
Anastrozole—Haemorrhage—Fluorouracil—head and neck cancer	0.00239	0.00431	CcSEcCtD
Anastrozole—Pharyngitis—Fluorouracil—head and neck cancer	0.00237	0.00428	CcSEcCtD
Anastrozole—Oedema—Hydroxyurea—head and neck cancer	0.00236	0.00425	CcSEcCtD
Anastrozole—Infection—Hydroxyurea—head and neck cancer	0.00234	0.00423	CcSEcCtD
Anastrozole—Paraesthesia—Vinblastine—head and neck cancer	0.00232	0.00419	CcSEcCtD
Anastrozole—Liver function test abnormal—Docetaxel—head and neck cancer	0.0023	0.00415	CcSEcCtD
Anastrozole—Anorexia—Hydroxyurea—head and neck cancer	0.00225	0.00406	CcSEcCtD
Anastrozole—Decreased appetite—Vinblastine—head and neck cancer	0.00225	0.00406	CcSEcCtD
Anastrozole—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00224	0.00405	CcSEcCtD
Anastrozole—Constipation—Vinblastine—head and neck cancer	0.00221	0.00399	CcSEcCtD
Anastrozole—Pain—Vinblastine—head and neck cancer	0.00221	0.00399	CcSEcCtD
Anastrozole—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.0022	0.00397	CcSEcCtD
Anastrozole—CYP1A2—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.00219	0.0311	CbGpPWpGaD
Anastrozole—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00218	0.031	CbGpPWpGaD
Anastrozole—Dysphagia—Docetaxel—head and neck cancer	0.00215	0.00389	CcSEcCtD
Anastrozole—Feeling abnormal—Vinblastine—head and neck cancer	0.00213	0.00384	CcSEcCtD
Anastrozole—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00211	0.00381	CcSEcCtD
Anastrozole—Alopecia—Fluorouracil—head and neck cancer	0.00211	0.00381	CcSEcCtD
Anastrozole—Dyspnoea—Hydroxyurea—head and neck cancer	0.0021	0.00379	CcSEcCtD
Anastrozole—Angina pectoris—Docetaxel—head and neck cancer	0.0021	0.00379	CcSEcCtD
Anastrozole—Somnolence—Hydroxyurea—head and neck cancer	0.0021	0.00378	CcSEcCtD
Anastrozole—Erythema—Fluorouracil—head and neck cancer	0.00208	0.00375	CcSEcCtD
Anastrozole—Dyspepsia—Hydroxyurea—head and neck cancer	0.00207	0.00374	CcSEcCtD
Anastrozole—Decreased appetite—Hydroxyurea—head and neck cancer	0.00205	0.0037	CcSEcCtD
Anastrozole—Abdominal pain—Vinblastine—head and neck cancer	0.00204	0.00369	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00203	0.00367	CcSEcCtD
Anastrozole—Fatigue—Hydroxyurea—head and neck cancer	0.00203	0.00367	CcSEcCtD
Anastrozole—Pain—Hydroxyurea—head and neck cancer	0.00202	0.00364	CcSEcCtD
Anastrozole—Constipation—Hydroxyurea—head and neck cancer	0.00202	0.00364	CcSEcCtD
Anastrozole—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00198	0.0282	CbGpPWpGaD
Anastrozole—Weight increased—Docetaxel—head and neck cancer	0.00196	0.00354	CcSEcCtD
Anastrozole—Weight decreased—Docetaxel—head and neck cancer	0.00195	0.00352	CcSEcCtD
Anastrozole—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00194	0.00351	CcSEcCtD
Anastrozole—Anaemia—Fluorouracil—head and neck cancer	0.00192	0.00347	CcSEcCtD
Anastrozole—Hypersensitivity—Vinblastine—head and neck cancer	0.0019	0.00344	CcSEcCtD
Anastrozole—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.0019	0.00344	CcSEcCtD
Anastrozole—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00189	0.00342	CcSEcCtD
Anastrozole—Myocardial infarction—Docetaxel—head and neck cancer	0.00188	0.0034	CcSEcCtD
Anastrozole—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00188	0.0034	CcSEcCtD
Anastrozole—Jaundice—Docetaxel—head and neck cancer	0.00187	0.00338	CcSEcCtD
Anastrozole—Body temperature increased—Hydroxyurea—head and neck cancer	0.00186	0.00336	CcSEcCtD
Anastrozole—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00186	0.0265	CbGpPWpGaD
Anastrozole—Leukopenia—Fluorouracil—head and neck cancer	0.00186	0.00336	CcSEcCtD
Anastrozole—Asthenia—Vinblastine—head and neck cancer	0.00185	0.00335	CcSEcCtD
Anastrozole—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00182	0.00328	CcSEcCtD
Anastrozole—Chest pain—Fluorouracil—head and neck cancer	0.00177	0.00319	CcSEcCtD
Anastrozole—Myalgia—Fluorouracil—head and neck cancer	0.00177	0.00319	CcSEcCtD
Anastrozole—Diarrhoea—Vinblastine—head and neck cancer	0.00177	0.00319	CcSEcCtD
Anastrozole—Discomfort—Fluorouracil—head and neck cancer	0.00175	0.00316	CcSEcCtD
Anastrozole—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00174	0.00313	CcSEcCtD
Anastrozole—Haemoglobin—Docetaxel—head and neck cancer	0.00173	0.00313	CcSEcCtD
Anastrozole—Rhinitis—Docetaxel—head and neck cancer	0.00173	0.00312	CcSEcCtD
Anastrozole—Hepatitis—Docetaxel—head and neck cancer	0.00172	0.00311	CcSEcCtD
Anastrozole—Haemorrhage—Docetaxel—head and neck cancer	0.00172	0.00311	CcSEcCtD
Anastrozole—Confusional state—Fluorouracil—head and neck cancer	0.00171	0.00309	CcSEcCtD
Anastrozole—Pharyngitis—Docetaxel—head and neck cancer	0.00171	0.00309	CcSEcCtD
Anastrozole—Dizziness—Vinblastine—head and neck cancer	0.00171	0.00308	CcSEcCtD
Anastrozole—Oedema peripheral—Docetaxel—head and neck cancer	0.0017	0.00306	CcSEcCtD
Anastrozole—Anaphylactic shock—Fluorouracil—head and neck cancer	0.0017	0.00306	CcSEcCtD
Anastrozole—Oedema—Fluorouracil—head and neck cancer	0.0017	0.00306	CcSEcCtD
Anastrozole—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00169	0.0241	CbGpPWpGaD
Anastrozole—Asthenia—Hydroxyurea—head and neck cancer	0.00169	0.00305	CcSEcCtD
Anastrozole—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.00169	0.024	CbGpPWpGaD
Anastrozole—Infection—Fluorouracil—head and neck cancer	0.00169	0.00304	CcSEcCtD
Anastrozole—Vomiting—Vinblastine—head and neck cancer	0.00164	0.00297	CcSEcCtD
Anastrozole—Erythema multiforme—Docetaxel—head and neck cancer	0.00163	0.00294	CcSEcCtD
Anastrozole—Headache—Vinblastine—head and neck cancer	0.00162	0.00292	CcSEcCtD
Anastrozole—Anorexia—Fluorouracil—head and neck cancer	0.00162	0.00292	CcSEcCtD
Anastrozole—Diarrhoea—Hydroxyurea—head and neck cancer	0.00161	0.00291	CcSEcCtD
Anastrozole—Dizziness—Hydroxyurea—head and neck cancer	0.00156	0.00281	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00155	0.00279	CcSEcCtD
Anastrozole—Nausea—Vinblastine—head and neck cancer	0.00153	0.00277	CcSEcCtD
Anastrozole—Insomnia—Fluorouracil—head and neck cancer	0.00153	0.00277	CcSEcCtD
Anastrozole—Paraesthesia—Fluorouracil—head and neck cancer	0.00152	0.00275	CcSEcCtD
Anastrozole—Alopecia—Docetaxel—head and neck cancer	0.00152	0.00275	CcSEcCtD
Anastrozole—Dyspnoea—Fluorouracil—head and neck cancer	0.00151	0.00273	CcSEcCtD
Anastrozole—Somnolence—Fluorouracil—head and neck cancer	0.00151	0.00272	CcSEcCtD
Anastrozole—Erythema—Docetaxel—head and neck cancer	0.0015	0.00271	CcSEcCtD
Anastrozole—Vomiting—Hydroxyurea—head and neck cancer	0.0015	0.0027	CcSEcCtD
Anastrozole—Dyspepsia—Fluorouracil—head and neck cancer	0.00149	0.0027	CcSEcCtD
Anastrozole—Rash—Hydroxyurea—head and neck cancer	0.00149	0.00268	CcSEcCtD
Anastrozole—Dermatitis—Hydroxyurea—head and neck cancer	0.00148	0.00268	CcSEcCtD
Anastrozole—Headache—Hydroxyurea—head and neck cancer	0.00148	0.00267	CcSEcCtD
Anastrozole—Decreased appetite—Fluorouracil—head and neck cancer	0.00147	0.00266	CcSEcCtD
Anastrozole—Dysgeusia—Docetaxel—head and neck cancer	0.00147	0.00265	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00146	0.00264	CcSEcCtD
Anastrozole—Back pain—Docetaxel—head and neck cancer	0.00145	0.00262	CcSEcCtD
Anastrozole—Pain—Fluorouracil—head and neck cancer	0.00145	0.00262	CcSEcCtD
Anastrozole—Nausea—Hydroxyurea—head and neck cancer	0.0014	0.00253	CcSEcCtD
Anastrozole—Feeling abnormal—Fluorouracil—head and neck cancer	0.0014	0.00252	CcSEcCtD
Anastrozole—Anaemia—Docetaxel—head and neck cancer	0.00139	0.0025	CcSEcCtD
Anastrozole—Urticaria—Fluorouracil—head and neck cancer	0.00135	0.00243	CcSEcCtD
Anastrozole—Leukopenia—Docetaxel—head and neck cancer	0.00134	0.00242	CcSEcCtD
Anastrozole—Body temperature increased—Fluorouracil—head and neck cancer	0.00134	0.00242	CcSEcCtD
Anastrozole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00134	0.019	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—XRCC3—head and neck cancer	0.00132	0.0188	CbGpPWpGaD
Anastrozole—Cough—Docetaxel—head and neck cancer	0.00131	0.00236	CcSEcCtD
Anastrozole—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.00131	0.0186	CbGpPWpGaD
Anastrozole—Hypertension—Docetaxel—head and neck cancer	0.0013	0.00234	CcSEcCtD
Anastrozole—Chest pain—Docetaxel—head and neck cancer	0.00128	0.00231	CcSEcCtD
Anastrozole—Myalgia—Docetaxel—head and neck cancer	0.00128	0.00231	CcSEcCtD
Anastrozole—Arthralgia—Docetaxel—head and neck cancer	0.00128	0.00231	CcSEcCtD
Anastrozole—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.00126	0.0179	CbGpPWpGaD
Anastrozole—Hypersensitivity—Fluorouracil—head and neck cancer	0.00125	0.00226	CcSEcCtD
Anastrozole—Dry mouth—Docetaxel—head and neck cancer	0.00125	0.00225	CcSEcCtD
Anastrozole—Confusional state—Docetaxel—head and neck cancer	0.00123	0.00223	CcSEcCtD
Anastrozole—Oedema—Docetaxel—head and neck cancer	0.00122	0.00221	CcSEcCtD
Anastrozole—Anaphylactic shock—Docetaxel—head and neck cancer	0.00122	0.00221	CcSEcCtD
Anastrozole—Infection—Docetaxel—head and neck cancer	0.00122	0.0022	CcSEcCtD
Anastrozole—CYP19A1—Tryptophan metabolism—CYP1A1—head and neck cancer	0.00122	0.0173	CbGpPWpGaD
Anastrozole—Pruritus—Fluorouracil—head and neck cancer	0.0012	0.00217	CcSEcCtD
Anastrozole—Anorexia—Docetaxel—head and neck cancer	0.00117	0.00211	CcSEcCtD
Anastrozole—Diarrhoea—Fluorouracil—head and neck cancer	0.00116	0.0021	CcSEcCtD
Anastrozole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00114	0.0162	CbGpPWpGaD
Anastrozole—Dizziness—Fluorouracil—head and neck cancer	0.00112	0.00202	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00112	0.00201	CcSEcCtD
Anastrozole—Insomnia—Docetaxel—head and neck cancer	0.00111	0.002	CcSEcCtD
Anastrozole—Paraesthesia—Docetaxel—head and neck cancer	0.0011	0.00198	CcSEcCtD
Anastrozole—Dyspnoea—Docetaxel—head and neck cancer	0.00109	0.00197	CcSEcCtD
Anastrozole—Somnolence—Docetaxel—head and neck cancer	0.00109	0.00196	CcSEcCtD
Anastrozole—Vomiting—Fluorouracil—head and neck cancer	0.00108	0.00195	CcSEcCtD
Anastrozole—Dyspepsia—Docetaxel—head and neck cancer	0.00108	0.00195	CcSEcCtD
Anastrozole—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00107	0.0152	CbGpPWpGaD
Anastrozole—Rash—Fluorouracil—head and neck cancer	0.00107	0.00193	CcSEcCtD
Anastrozole—Dermatitis—Fluorouracil—head and neck cancer	0.00107	0.00193	CcSEcCtD
Anastrozole—Decreased appetite—Docetaxel—head and neck cancer	0.00106	0.00192	CcSEcCtD
Anastrozole—Headache—Fluorouracil—head and neck cancer	0.00106	0.00192	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00106	0.00191	CcSEcCtD
Anastrozole—Fatigue—Docetaxel—head and neck cancer	0.00106	0.00191	CcSEcCtD
Anastrozole—CYP2C9—Xenobiotics—CYP1A1—head and neck cancer	0.00105	0.0149	CbGpPWpGaD
Anastrozole—Pain—Docetaxel—head and neck cancer	0.00105	0.00189	CcSEcCtD
Anastrozole—Constipation—Docetaxel—head and neck cancer	0.00105	0.00189	CcSEcCtD
Anastrozole—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.00103	0.0146	CbGpPWpGaD
Anastrozole—Feeling abnormal—Docetaxel—head and neck cancer	0.00101	0.00182	CcSEcCtD
Anastrozole—Nausea—Fluorouracil—head and neck cancer	0.00101	0.00182	CcSEcCtD
Anastrozole—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00101	0.0143	CbGpPWpGaD
Anastrozole—Gastrointestinal pain—Docetaxel—head and neck cancer	0.001	0.00181	CcSEcCtD
Anastrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000983	0.014	CbGpPWpGaD
Anastrozole—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.000974	0.0138	CbGpPWpGaD
Anastrozole—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00097	0.0138	CbGpPWpGaD
Anastrozole—Body temperature increased—Docetaxel—head and neck cancer	0.000968	0.00175	CcSEcCtD
Anastrozole—Abdominal pain—Docetaxel—head and neck cancer	0.000968	0.00175	CcSEcCtD
Anastrozole—CYP19A1—Biological oxidations—NAT2—head and neck cancer	0.000904	0.0128	CbGpPWpGaD
Anastrozole—Hypersensitivity—Docetaxel—head and neck cancer	0.000902	0.00163	CcSEcCtD
Anastrozole—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.000895	0.0127	CbGpPWpGaD
Anastrozole—CYP19A1—Metapathway biotransformation—NAT2—head and neck cancer	0.000891	0.0127	CbGpPWpGaD
Anastrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000882	0.0125	CbGpPWpGaD
Anastrozole—Asthenia—Docetaxel—head and neck cancer	0.000878	0.00159	CcSEcCtD
Anastrozole—Pruritus—Docetaxel—head and neck cancer	0.000866	0.00156	CcSEcCtD
Anastrozole—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000861	0.0122	CbGpPWpGaD
Anastrozole—Diarrhoea—Docetaxel—head and neck cancer	0.000838	0.00151	CcSEcCtD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—RAD51—head and neck cancer	0.000835	0.0119	CbGpPWpGaD
Anastrozole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000826	0.0117	CbGpPWpGaD
Anastrozole—CYP19A1—FSH signaling pathway—MAPK3—head and neck cancer	0.000825	0.0117	CbGpPWpGaD
Anastrozole—Dizziness—Docetaxel—head and neck cancer	0.00081	0.00146	CcSEcCtD
Anastrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000797	0.0113	CbGpPWpGaD
Anastrozole—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000793	0.0113	CbGpPWpGaD
Anastrozole—CYP19A1—FSH signaling pathway—MAPK1—head and neck cancer	0.000785	0.0111	CbGpPWpGaD
Anastrozole—Vomiting—Docetaxel—head and neck cancer	0.000778	0.00141	CcSEcCtD
Anastrozole—Rash—Docetaxel—head and neck cancer	0.000772	0.00139	CcSEcCtD
Anastrozole—Dermatitis—Docetaxel—head and neck cancer	0.000771	0.00139	CcSEcCtD
Anastrozole—Headache—Docetaxel—head and neck cancer	0.000767	0.00138	CcSEcCtD
Anastrozole—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000751	0.0107	CbGpPWpGaD
Anastrozole—Nausea—Docetaxel—head and neck cancer	0.000727	0.00131	CcSEcCtD
Anastrozole—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000691	0.00981	CbGpPWpGaD
Anastrozole—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000665	0.00944	CbGpPWpGaD
Anastrozole—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000664	0.00943	CbGpPWpGaD
Anastrozole—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000586	0.00832	CbGpPWpGaD
Anastrozole—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.000584	0.0083	CbGpPWpGaD
Anastrozole—CYP19A1—FSH signaling pathway—AKT1—head and neck cancer	0.000556	0.0079	CbGpPWpGaD
Anastrozole—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000508	0.00722	CbGpPWpGaD
Anastrozole—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000503	0.00715	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.00046	0.00653	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.00046	0.00653	CbGpPWpGaD
Anastrozole—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.00046	0.00653	CbGpPWpGaD
Anastrozole—CYP19A1—Biological oxidations—GSTM1—head and neck cancer	0.000446	0.00634	CbGpPWpGaD
Anastrozole—CYP19A1—Metapathway biotransformation—GSTM1—head and neck cancer	0.00044	0.00625	CbGpPWpGaD
Anastrozole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000435	0.00618	CbGpPWpGaD
Anastrozole—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000434	0.00617	CbGpPWpGaD
Anastrozole—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.00043	0.00611	CbGpPWpGaD
Anastrozole—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000429	0.0061	CbGpPWpGaD
Anastrozole—CYP19A1—Biological oxidations—CYP1A1—head and neck cancer	0.000423	0.00601	CbGpPWpGaD
Anastrozole—CYP19A1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000417	0.00593	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.0004	0.00568	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000394	0.0056	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—UROD—head and neck cancer	0.000372	0.00529	CbGpPWpGaD
Anastrozole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000372	0.00528	CbGpPWpGaD
Anastrozole—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000367	0.00521	CbGpPWpGaD
Anastrozole—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000355	0.00504	CbGpPWpGaD
Anastrozole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000352	0.00501	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.000343	0.00487	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000342	0.00485	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.000339	0.00481	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000337	0.00479	CbGpPWpGaD
Anastrozole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000301	0.00428	CbGpPWpGaD
Anastrozole—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000299	0.00425	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.000294	0.00418	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000289	0.0041	CbGpPWpGaD
Anastrozole—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000289	0.0041	CbGpPWpGaD
Anastrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000287	0.00407	CbGpPWpGaD
Anastrozole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000283	0.00402	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000273	0.00388	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000264	0.00375	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.00026	0.0037	CbGpPWpGaD
Anastrozole—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000256	0.00363	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000253	0.0036	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.000252	0.00358	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000244	0.00346	CbGpPWpGaD
Anastrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000232	0.0033	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.00022	0.00312	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000215	0.00306	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.000198	0.00281	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.000198	0.00281	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.000198	0.00281	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000195	0.00277	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.000194	0.00275	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.000194	0.00275	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.000194	0.00275	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	0.000187	0.00266	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000185	0.00262	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	0.000169	0.0024	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	0.000166	0.00236	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.000166	0.00236	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—UROD—head and neck cancer	0.000165	0.00234	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000164	0.00233	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000162	0.00231	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	0.00016	0.00227	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000158	0.00224	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000156	0.00221	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—NAT2—head and neck cancer	0.000155	0.0022	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—UROD—head and neck cancer	0.000141	0.002	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.00014	0.00199	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—DPYD—head and neck cancer	0.000136	0.00193	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.00013	0.00185	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—YAP1—head and neck cancer	0.000129	0.00183	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000128	0.00182	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000128	0.00182	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000123	0.00175	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000122	0.00173	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000109	0.00155	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—UROD—head and neck cancer	0.000109	0.00154	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	9.66e-05	0.00137	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	8.43e-05	0.0012	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—TYMS—head and neck cancer	7.72e-05	0.0011	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GSTM1—head and neck cancer	7.63e-05	0.00108	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GPX1—head and neck cancer	7.31e-05	0.00104	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	7.26e-05	0.00103	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CYP1A1—head and neck cancer	7.24e-05	0.00103	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	7.19e-05	0.00102	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—NAT2—head and neck cancer	6.84e-05	0.000972	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	6.21e-05	0.000882	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	6.14e-05	0.000873	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—DPYD—head and neck cancer	6e-05	0.000852	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.95e-05	0.000845	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—NAT2—head and neck cancer	5.84e-05	0.00083	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—YAP1—head and neck cancer	5.69e-05	0.000808	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—DPYD—head and neck cancer	5.12e-05	0.000728	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—YAP1—head and neck cancer	4.86e-05	0.000691	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—NAT2—head and neck cancer	4.51e-05	0.000641	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PTGS2—head and neck cancer	4.3e-05	0.000611	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.28e-05	0.000607	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—DPYD—head and neck cancer	3.96e-05	0.000562	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—YAP1—head and neck cancer	3.75e-05	0.000533	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PTEN—head and neck cancer	3.75e-05	0.000533	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.73e-05	0.00053	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.65e-05	0.000519	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—TYMS—head and neck cancer	3.42e-05	0.000485	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GSTM1—head and neck cancer	3.38e-05	0.00048	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GPX1—head and neck cancer	3.23e-05	0.000459	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP1A1—head and neck cancer	3.2e-05	0.000455	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.19e-05	0.000453	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—TYMS—head and neck cancer	2.92e-05	0.000415	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTM1—head and neck cancer	2.89e-05	0.00041	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GPX1—head and neck cancer	2.76e-05	0.000393	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP1A1—head and neck cancer	2.74e-05	0.000389	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PIK3CA—head and neck cancer	2.65e-05	0.000376	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.63e-05	0.000374	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—TYMS—head and neck cancer	2.25e-05	0.00032	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.25e-05	0.000319	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTM1—head and neck cancer	2.23e-05	0.000316	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—AKT1—head and neck cancer	2.16e-05	0.000307	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GPX1—head and neck cancer	2.13e-05	0.000303	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP1A1—head and neck cancer	2.11e-05	0.0003	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.9e-05	0.000271	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PTEN—head and neck cancer	1.66e-05	0.000236	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PTGS2—head and neck cancer	1.63e-05	0.000231	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PTEN—head and neck cancer	1.42e-05	0.000202	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.26e-05	0.000178	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PIK3CA—head and neck cancer	1.17e-05	0.000166	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PTEN—head and neck cancer	1.1e-05	0.000156	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1e-05	0.000142	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—AKT1—head and neck cancer	9.57e-06	0.000136	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—AKT1—head and neck cancer	8.18e-06	0.000116	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PIK3CA—head and neck cancer	7.73e-06	0.00011	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—AKT1—head and neck cancer	6.31e-06	8.97e-05	CbGpPWpGaD
